Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Tiberghien

Showing results (1-10 of 148) with videos related to

Pageof 15
Sort By:
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|January 1, 1997
[Modulation of alloreactivity using genetically modified T lymphocytes]P Tiberghien
Journal of Leukocyte Biology|August 1, 1994
Use of suicide genes in gene therapyP Tiberghien
Current Opinion in Hematology|November 14, 1998
"Suicide" gene for the control of graft-versus-host diseaseP Tiberghien
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|September 10, 2021
Increasing unpaid plasma collection by blood establishments to ensure availability of plasma-derived medicinal products and blood components in EuropeP Tiberghien
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 1, 2014
[Research at the Établissement Français du Sang, the French transfusion public service: challenges and responsibilities]P Tiberghien
Journal of Internal Medicine|April 12, 2001
Use of suicide gene-expressing donor T-cells to control alloreactivity after haematopoietic stem cell transplantationP Tiberghien
Transfusion Science|December 10, 1991
Perspectives in marrow graft T-cell depletion in allogeneic matched related bone marrow transplantationP Tiberghien, P Hervé
La Revue Du Praticien|August 16, 2001
[Challenges of transfusion medicine]P Hervé, P Tiberghien
Hematology and Cell Therapy|August 1, 1997
The emergence of cell therapy in France. Public health, regulations and other controversial issuesP Hervé, P Tiberghien
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|May 26, 1999
[Erythrocyte transfusion practices after allogeneic hematopoietic stem cell transplantation]V Lapierre, M Kuentz, P Tiberghien
Pageof 15

Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|January 1, 1997
[Modulation of alloreactivity using genetically modified T lymphocytes]P Tiberghien
Journal of Leukocyte Biology|August 1, 1994
Use of suicide genes in gene therapyP Tiberghien
Current Opinion in Hematology|November 14, 1998
"Suicide" gene for the control of graft-versus-host diseaseP Tiberghien
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|September 10, 2021
Increasing unpaid plasma collection by blood establishments to ensure availability of plasma-derived medicinal products and blood components in EuropeP Tiberghien
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 1, 2014
[Research at the Établissement Français du Sang, the French transfusion public service: challenges and responsibilities]P Tiberghien
Journal of Internal Medicine|April 12, 2001
Use of suicide gene-expressing donor T-cells to control alloreactivity after haematopoietic stem cell transplantationP Tiberghien
Transfusion Science|December 10, 1991
Perspectives in marrow graft T-cell depletion in allogeneic matched related bone marrow transplantationP Tiberghien, P Hervé
La Revue Du Praticien|August 16, 2001
[Challenges of transfusion medicine]P Hervé, P Tiberghien
Hematology and Cell Therapy|August 1, 1997
The emergence of cell therapy in France. Public health, regulations and other controversial issuesP Hervé, P Tiberghien
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|May 26, 1999
[Erythrocyte transfusion practices after allogeneic hematopoietic stem cell transplantation]V Lapierre, M Kuentz, P Tiberghien
Pageof 15